ArticlePharmaceuticals (Basel, Switzerland)2026
Neuroprotective Indole Diterpenoids from the Fungus
Ai-Lin Liang, Chao Wang, Xing-Yi Chen, Yu-Feng Tan, Wen-Yu Lu, Peng-Ju Xu, Hong-Ping Long, Shao Liu, Jing Li, Wen-Xuan Wang and 1 more
Abstract read
In one paragraphArticle in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Ai-Lin LiangDepartment of Pharmacy, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha 410008, China.
Chao WangEye Center of Xiangya Hospital, Central South University, Changsha 410083, China.
Xing-Yi ChenEye Center of Xiangya Hospital, Central South University, Changsha 410083, China.
Yu-Feng TanXiangya School of Pharmaceutical Sciences, Central South University, Changsha 410083, China.
Wen-Yu LuXiangya School of Pharmaceutical Sciences, Central South University, Changsha 410083, China.
Peng-Ju XuXiangya School of Pharmaceutical Sciences, Central South University, Changsha 410083, China.
Hong-Ping LongCenter for Medical Research and Innovation, The First Hospital of Hunan University of Chinese Medicine, Changsha 410007, China.
Shao LiuDepartment of Pharmacy, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha 410008, China.ORCID 0000-0002-0576-8698 Jing LiDepartment of Pharmacy, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha 410008, China.ORCID 0000-0001-8133-507X Wen-Xuan WangXiangya School of Pharmaceutical Sciences, Central South University, Changsha 410083, China.ORCID 0000-0002-7391-2954 Funding
Fundamental Research Funds for the Central Universities of Central South University 2024ZZTS0990Fundamental Research Funds for the Central Universities of Central South University 2025ZZTS0913Key Research and Development Program of Hunan Province 2022SK2031National Natural Science Foundation of China 82101127Natural Science Foundation of Hunan Province 2024JJ8127
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
ferroptosisneuroprotective activitiesOphiocordycipitaceaepaxilline-type indole diterpenoidsTolypocladium album
Identifiers
PMID42356426
PMCPMC13304572
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390